Cowen & Co. Maintains Outperform on Sema4 Holdings, Lowers Price Target to $3
Cowen & Co. analyst Max Masucci maintains Sema4 Holdings (NASDAQ:SMFR) with a Outperform and lowers the price target from $5 to $3.
Earnings Scheduled For November 14, 2022
Companies Reporting Before The Bell
• Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
AT&T, IBM, Las Vegas Sands And Some Other Big Stocks Moving Higher On Thursday
U.S. stocks traded higher, with the Dow Jones gaining more than 100 points on Thursday. Here are some big stocks recording gains in today’s session.
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's trading, 517 companies set new 52-week lows.
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 574 stocks hit new 52-week lows.
